Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Lymphoma 1 Leukemia 1 Leiomyoma 1 Hypertension 1 Breast Neoplasms 1

Interventions

Nutrition Assessment 4 Bevacizumab 3 Lisinopril 2 Labetalol 2 Hydrochlorothiazide 2 Angiotensin-Converting Enzyme Inhibitors 2 ziprasidone 1 pazopanib 1 ganirelix 1 enzalutamide 1 clevidipine 1 bicalutamide 1 benazepril 1 aliskiren 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1 Tumor Necrosis Factors 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1 Therapeutics 1 Surveys and Questionnaires 1 Sunitinib 1 Sulindac 1 Standard of Care 1 Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hypertension × Nitroprusside × Clear all

NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡